|
|
| 61. |
Gastroenteropancreatic Endocrine Tumours: Effects of Octreotide Treatment |
| |
Digestive Surgery,
Volume 11,
Issue 3-6,
1994,
Page 461-464
R.F. Meier,
Preview
|
PDF (696KB)
|
|
摘要:
Octreotide is particularly useful in patients with resistant acromegaly and some gastroenteropancreatic (GEP) tumours, e.g. VIPomas, carcinoids and glucagonomas. The efficacy of octreotide can be attributed to its action regarding somatostatin receptors on GEP tumour cells. The symptoms of these tumours are due to a greater extent to the peptides they secrete than to their actual size. In most patients these symptoms improve or disappear completely with octreotide treatment. Side effects of treatment are mainly mild and do not necessitate withdrawal of the treatment. Octreotide is currently the drug of choice for controlling the symptoms of inoperable GEP tumours.
ISSN:0253-4886
DOI:10.1159/000172303
出版商:S. Karger AG
年代:1994
数据来源: Karger
|
| 62. |
Author Index Vol. 11, 1994 |
| |
Digestive Surgery,
Volume 11,
Issue 3-6,
1994,
Page 465-466
Preview
|
PDF (200KB)
|
|
ISSN:0253-4886
DOI:10.1159/000172304
出版商:S. Karger AG
年代:1994
数据来源: Karger
|
| 63. |
Subject Index Vol. 11, 1994 |
| |
Digestive Surgery,
Volume 11,
Issue 3-6,
1994,
Page 467-468
Preview
|
PDF (289KB)
|
|
ISSN:0253-4886
DOI:10.1159/000172305
出版商:S. Karger AG
年代:1994
数据来源: Karger
|
| 64. |
Contents, Vol. 11, 1994 |
| |
Digestive Surgery,
Volume 11,
Issue 3-6,
1994,
Page -
Preview
|
PDF (677KB)
|
|
ISSN:0253-4886
DOI:10.1159/000172238
出版商:S. Karger AG
年代:1994
数据来源: Karger
|
|
首页
Volume 11 issue 3-6